Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00217581
Status:
COMPLETED
Last Update Posted:
2019-03-26
First Post:
2005-09-20
Brief Title:
Bevacizumab Oxaliplatin and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Barbara Ann Karmanos Cancer Institute
Organization Data
Organization:
Barbara Ann Karmanos Cancer Institute
Class:
OTHER
Study ID:
CDR0000441641
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Barbara Ann Karmanos Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Philip Philip
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Barbara Ann Karmanos Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |